PublizoomAward notice Supplies
Εκαπυ 11/2024 φαρμακα
Notice published in Greek. The AI analysis summarises it for you in your language.
- Public buyer
- Εθνική Κεντρική Αρχή Προμηθειών Υγείας (E.K.A.Π.Υ.)
Αθήνα - Place of performance
- ΑΘΗΝΑ
- Estimated value
- €16,579,758 excl. VAT
- Amount awarded
- €16,579,758 excl. VAT
- Planned end of contract
- 18 September 2029
likely re-tender around March 2029 - Bids received
- 1
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 14 October 2026
- Notice language
- Greek
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
ΕΚΑΠΥ 11/2024 ΦΑΡΜΑΚΑ
Awarded to
5 lots
- Α/Α 1 AMIKACIN INJ.SOL 500MG/VIAL/BOTTLE/AMP
- Α/Α 2 CISATRACURIUM BESILATE INJ.SO.INF / INJ.SOL 20MG/VIALL
- A/Α 3 DEXAMETHASONE INJ.SOL8MG/2ML
- Α/Α 4 ITRACONAZOLE C.SO.S.INF 10MG/ML
- Α/Α 5 METRONIDAZOLE SOL.IV.INF 500MG/100ML VIAL
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €129,724
- Median
- €175,195
- A quarter above
- €278,460
Amounts awarded (excl. VAT) over the last 3 years for 37 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 709180-2026.